GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
25/05/22	GSK	15:41:00	25 May 2022	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
01/12/21	GSK	11:05:00	1 Dec 2021	Total Voting Rights	GSK	Total Voting Rights	GSK plc	PRN
30/11/18		16:40:27	30 Nov 2018	Second Price Monitoring Extn		Second Price Monitoring Extn	GlaxoSmithKline PLC	RNS
30/11/18		16:35:31	30 Nov 2018	Price Monitoring Extension		Price Monitoring Extension	GlaxoSmithKline PLC	RNS
29/11/18		15:40:42	29 Nov 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
29/11/18		11:45:03	29 Nov 2018	GSK - Update on Review of Horlicks		GSK - Update on Review of Horlicks	GlaxoSmithKline PLC	RNS
27/11/18		15:25:31	27 Nov 2018	Block listing Interim Review		Block listing Interim Review	GlaxoSmithKline PLC	RNS
22/11/18		13:02:01	22 Nov 2018	GSK publishes 2019 Dividend Dates		GSK publishes 2019 Dividend Dates	GlaxoSmithKline PLC	RNS
12/11/18		14:45:05	12 Nov 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
12/11/18		09:00:02	12 Nov 2018	Blocklisting Application		Blocklisting Application	GlaxoSmithKline PLC	RNS
08/11/18		12:43:52	8 Nov 2018	Director Declaration		Director Declaration	GlaxoSmithKline PLC	RNS
02/11/18		16:15:01	2 Nov 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
01/11/18		13:40:01	1 Nov 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
31/10/18		14:15:01	31 Oct 2018	ViiV positive phIII results with fostemsavir		ViiV positive phIII results with fostemsavir	GlaxoSmithKline PLC	RNS
31/10/18		12:07:38	31 Oct 2018	Second Price Monitoring Extn		Second Price Monitoring Extn	GlaxoSmithKline PLC	RNS
31/10/18		12:02:32	31 Oct 2018	Price Monitoring Extension		Price Monitoring Extension	GlaxoSmithKline PLC	RNS
31/10/18		12:00:01	31 Oct 2018	3rd Quarter Results		3rd Quarter Results	GlaxoSmithKline PLC	RNS
30/10/18		14:30:04	30 Oct 2018	ViiV: positive data for long-acting injectable		ViiV: positive data for long-acting injectable	GlaxoSmithKline PLC	RNS
29/10/18		10:00:03	29 Oct 2018	ViiV - three-year data for long-acting injectable		ViiV - three-year data for long-acting injectable	GlaxoSmithKline PLC	RNS
18/10/18		17:00:31	18 Oct 2018	ViiV submits HIV 2DR regulatory application to FDA		ViiV submits HIV 2DR regulatory application to FDA	GlaxoSmithKline PLC	RNS
18/10/18		10:34:36	18 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/10/18		18:56:20	17 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/10/18		18:50:32	17 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
17/10/18		12:30:01	17 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/10/18		17:53:53	16 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/10/18		10:30:04	16 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
16/10/18		10:30:04	16 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
10/10/18		16:30:04	10 Oct 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
01/10/18		14:58:47	1 Oct 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
27/09/18		17:35:01	27 Sept 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
14/09/18		10:00:01	14 Sept 2018	ViiV submits HIV 2DR regulatory application to EMA		ViiV submits HIV 2DR regulatory application to EMA	GlaxoSmithKline PLC	RNS
12/09/18		18:43:15	12 Sept 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
10/09/18		09:00:04	10 Sept 2018	New analysis on efficacy of anti-IL5 biologics SEA		New analysis on efficacy of anti-IL5 biologics SEA	GlaxoSmithKline PLC	RNS
10/09/18		08:00:03	10 Sept 2018	GSK receives CRL from FDA for mepolizumab in COPD		GSK receives CRL from FDA for mepolizumab in COPD	GlaxoSmithKline PLC	RNS
07/09/18		15:24:38	7 Sept 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
07/09/18		15:18:32	7 Sept 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
30/08/18		18:12:51	30 Aug 2018	GSK publishes Q4 2018 Dividend Dates		GSK publishes Q4 2018 Dividend Dates	GlaxoSmithKline PLC	RNS
30/08/18		09:12:15	30 Aug 2018	EU approve Nucala in severe asthma in children		EU approve Nucala in severe asthma in children	GlaxoSmithKline PLC	RNS
24/08/18		11:16:55	24 Aug 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
15/08/18		08:00:03	15 Aug 2018	Positive headline results for ViiV HC ATLAS study		Positive headline results for ViiV HC ATLAS study	GlaxoSmithKline PLC	RNS
10/08/18		16:00:03	10 Aug 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
08/08/18		13:35:03	8 Aug 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
02/08/18		12:04:49	2 Aug 2018	Total Voting Rights		Total Voting Rights	GlaxoSmithKline PLC	RNS
31/07/18		18:03:34	31 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
31/07/18		17:37:35	31 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
27/07/18		17:30:05	27 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS
27/07/18		15:47:26	27 Jul 2018	CHMP recommend Nucala for severe asthma children		CHMP recommend Nucala for severe asthma children	GlaxoSmithKline PLC	RNS
26/07/18		08:00:01	26 Jul 2018	GSK reports on FDA Ad Com on mepolizumab for COPD		GSK reports on FDA Ad Com on mepolizumab for COPD	GlaxoSmithKline PLC	RNS
25/07/18		17:15:00	25 Jul 2018	Director/PDMR Shareholding		Director/PDMR Shareholding	GlaxoSmithKline PLC	RNS

Showing 1451–1500 of 2,805 announcements